ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Associate Oligonucleotide Chemist at Eli Lilly and Company - ApplyBlast

Associate Oligonucleotide Chemist

Eli Lilly and Company

5 months ago

4.0 on Glassdoor

Remote

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

RNA Therapeutics team member focusing on oligonucleotide-based therapeutics and delivery approaches

Responsibilities

Synthesize, purify, and analyze modified oligonucleotides, conjugates, and small molecules
Champion an effective and proactive safety culture
Independently troubleshoot synthetic challenges and drive continuous improvement of laboratory workflows
Maintain high laboratory productivity including the operation and maintenance of an oligonucleotide synthesizer
Collaborate with chemists and scientists across fields to deliver on shared project goals

Skills

Qualifications

BS/MS in Chemistry or related field1-2 years of experience in synthetic organic and/or oligonucleotide chemistry

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.